[1] |
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917.
|
[2] |
Song HY, Lee HK, Lee JS, et al. Risk factors of cryptogenic hepatocellular carcinoma in patients with low body mass index or without metabolic syndrome[J]. Korean J Intern Med, 2012, 27(1):47-52.
|
[3] |
中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)摘要[J].中华肝脏病杂志,2012, 20(6):419-426.
|
[4] |
Forner A, Reig ME, de Lope CR, et al. Current strategy for staging and treatment: the BCLC update and future prospects[J]. Semin Liver Dis, 2010, 30(1):61-74.
|
[5] |
陈建国,陆建华,朱源荣,等.乙型肝炎病毒感染与肝癌发生的31年随访研究[J].中华流行病学杂志,2010, 31(7):721-726.
|
[6] |
Pollicino T, Squadrito G, Cerenzia G, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection[J]. Gastroenterology, 2004, 126(1):102-110.
|
[7] |
Ikeda K, Kobayashi M, Someya T, et al. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study[J]. J Viral Hepat, 2009, 16(6):437-443.
|
[8] |
Chen CH, Changchien CS, Lee CM, et al. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan[J]. Int J Cancer, 2009, 125(3):621-629.
|
[9] |
De Mitri MS, Cassini R, Bernardi M. Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections[J]. Eur J Cancer, 2010, 46(12):2178-2186.
|
[10] |
Wong DK, Huang FY, Lai CL, et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma[J]. Hepatology, 2011, 54(3):829-836.
|
[11] |
Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation[J]. J Viral Hepat, 2010, 17(1):1-15.
|
[12] |
Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection[J]. Hepatology, 2010, 51(5):1820-1832.
|
[13] |
de Lope CR, Tremosini S, Forner A, et al. Management of HCC[J]. J Hepatol, 2012, 56 Suppl 1:S75-87.
|
[14] |
Rampone B, Schiavone B, Martino A, et al. Current management strategy of hepatocellular carcinoma[J]. World J Gastroenterol, 2009, 15(26):3210-3216.
|
[15] |
陈骋,潘楚芝,钟跃思,等.家族聚集性肝细胞肝癌患者40例临床分析[J/CD].中华肝脏外科手术学电子杂志,2013, 2(5):294-297.
|
[16] |
颜见,姚志成,钟跃思,等.肝细胞肝癌840例临床分析[J/CD].中华肝脏外科手术学电子杂志,2012, 1(1):33-37.
|